BZYR News Alert Burzynski Research (BZYR) 0.1300 10/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Burzynski Research (BZYR) 0.1300 $BZYR

Burzynski Research Institute, Inc. Announces Presentations at the 16th International Symposium on Pediatric Neuro-Oncology
PR Newswire - Fri Jun 27, 12:08PM CDT
The Burzynski Research Institute, Inc. (BRI) announced today that it will present data on two of the Company's clinical-stage product candidates, Antineoplaston A10 injections (Atengenal®) and Antineoplaston AS2-1 injections (Astugenal®), at the 16th International Symposium on Pediatric Neuro-Oncology held in Singapore from June 28, 2014 to July 2, 2014. Abstracts and presentations are now available to the public in an online supplement in the journal, Neuro-Oncology (Neuro Oncol 2014 June; 16(Suppl 1): i1-i157). The abstract numbers are CT-004, HG-017, and MB-039. The journal's TOC web address is http://neuro-oncology.oxfordjournals.org/cont...uppl_1.toc.

Burzynski Research Institute, Inc. Announces Lifting of the FDA Partial Clinical Hold - Phase 3 Clinical Study Agreed Upon
PR Newswire - Mon Jun 23, 3:07PM CDT
The Burzynski Research Institute, Inc. (BRI) announced today that U.S. Food and Drug Administration (FDA) has notified the company that its partial clinical hold on its IND for Antineoplastons A10/AS2-1 Injections has been lifted. The FDA has determined that under its IND the Company may initiate its planned Phase 3 study in newly diagnosed diffuse, intrinsic, brainstem glioma. The Company is continuing discussions with the Agency in an effort to finalize additional details of the phase 3 study protocol for the potential clinical trial.

Astrocytoma Global Clinical Trials Review, H2, 2012
M2 - Fri Jan 18, 3:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/nnsfxh/astrocytoma) has announced the addition of GlobalData's new report "Astrocytoma Global Clinical Trials Review, H2, 2012" to their offering. Astrocytoma Global Clinical Trials Review, H2, 2012" provides data on the Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Astrocytoma. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 154

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 111

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 61

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 137

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Charter’s $1.5 Billion Tender Tests Debt Discipline

Updated Category News Views 0

Debt cleanup arrives with a hard ceiling Eight far-dated bond issues just got a very specific invitation from Charter Communications: hand them over for cash, but do not expect the company to write a blank check. Charter set final pricing on November 17 for tender offers covering up to $1.5 billion in aggregate consideration, excluding accrued interest and deal expenses....

Continue Reading
Bank of America AML Claims Put Controls Under Fire

Updated Category News Views 0

A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...

Continue Reading
SGRY Acquisition Under Scrutiny: Fairness Questioned

Updated Category News Views 232

Questions Hover Over SGRY Acquisition Here's a real jaw-dropper for you. Surgery Partners, Inc. (NASDAQ: SGRY) is getting clocks cleaned in a fairness probe over its acquisition terms. If you thought this ride was smooth, think again—Levi & Korsinsky, LLP has put the brakes on any such assumptions, launching an investigation that’s sure to raise some eyebrows. What's...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 60

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 88

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring HUYABIO's Innovative Approach to AF Treatment

Updated Category News Views 146

Revolutionizing Atrial Fibrillation Therapy with HBI-3000 HUYABIO International is making significant strides in addressing atrial fibrillation (AF), a prevalent heart condition affecting millions globally. Their innovative antiarrhythmic drug, HBI-3000, is designed to fill critical gaps in AF management. Understanding Atrial Fibrillation Atrial fibrillation is known for...

Continue Reading
EQT Real Estate Expands Logistics Portfolio in Italy's Market

Updated Category News Views 161

EQT Real Estate Expands Logistics Portfolio in Italy's Market EQT Real Estate is thrilled to announce the acquisition of a remarkable logistics assemblage comprising 12 high-quality, fully let assets. This collection spans a total of 265,000 square meters and represents a significant milestone in our ongoing commitment to enhancing our logistics portfolio. Strategic...

Continue Reading
Qmerit Launches PowerForce: A Game-Changer for Electrical Services

Updated Category News Views 172

Introducing PowerForce by Qmerit™ PowerForce by Qmerit™ is revolutionizing the way commercial and multi-site residential property managers approach electrical services. This innovative solution harnesses the power of AI to streamline electrical maintenance, repairs, and upgrade projects, making it an invaluable tool for effective property management. A Comprehensive...

Continue Reading
Discover Remittix: Your Gateway to a Crypto Revolution

Updated Category News Views 363

Introducing Remittix's Innovative Web3 Wallet In the ever-evolving world of cryptocurrency, practicality triumphs over noise, and Remittix is leading the way. This exciting project has just launched its Web3 wallet into beta testing phase and is ready to take crypto to the next level by supporting major networks like Bitcoin, Ethereum, Solana, and Tron. With an impressive...

Continue Reading
Revolutionizing Insights: Engine's AI for CPG and Retail Sectors

Updated Category News Views 230

Engine Unveils Auto Insights Engine for Enhanced Retail Analysis Engine has taken a significant step forward in the realm of analytics and data science with the introduction of its latest innovation, the Auto Insights Engine. This robust tool serves as an 'always-on AI analyst' that diligently monitors data to identify trends, investigate underlying causes, and yield...

Continue Reading